$707 Million is the total value of Consonance Capital Management LP's 22 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $94,826,000 | +39.4% | 1,560,157 | +40.6% | 13.42% | +30.4% |
| MDVN | Sell | MEDIVATION INC | $76,581,000 | +23.4% | 1,270,000 | -5.9% | 10.84% | +15.4% |
| ARIA | Buy | ARIAD PHARMACEUTICALS INC | $65,370,000 | +83.5% | 8,845,742 | +58.6% | 9.25% | +71.6% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $64,448,000 | +19.2% | 4,929,139 | -0.3% | 9.12% | +11.5% |
| OFIX | Sell | ORTHOFIX INTL N V | $51,919,000 | -17.0% | 1,224,496 | -18.7% | 7.35% | -22.3% |
| RTRX | Sell | RETROPHIN INC | $48,086,000 | +28.9% | 2,699,947 | -1.1% | 6.81% | +20.6% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $45,630,000 | +31.8% | 817,456 | -20.5% | 6.46% | +23.3% |
| DEPO | Sell | DEPOMED INC | $44,641,000 | +16.3% | 2,275,300 | -17.5% | 6.32% | +8.8% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $44,349,000 | – | 418,700 | +100.0% | 6.28% | – |
| PEN | Buy | PENUMBRA INC | $40,703,000 | +2112.1% | 684,079 | +1610.2% | 5.76% | +1972.3% |
| CLVS | New | CLOVIS ONCOLOGY INC | $40,289,000 | – | 2,936,487 | +100.0% | 5.70% | – |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $18,699,000 | -33.5% | 482,047 | -30.5% | 2.65% | -37.7% |
| NXTM | New | NXSTAGE MEDICAL INC | $18,106,000 | – | 835,134 | +100.0% | 2.56% | – |
| CPHD | New | CEPHEID | $13,950,000 | – | 453,662 | +100.0% | 1.97% | – |
| NUVA | Sell | NUVASIVE INC | $9,866,000 | -79.8% | 165,203 | -83.6% | 1.40% | -81.1% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $7,840,000 | -79.6% | 1,114,448 | -75.3% | 1.11% | -80.9% |
| ADMA | Buy | ADMA BIOLOGICS INC | $7,580,000 | -11.6% | 1,273,933 | +20.2% | 1.07% | -17.3% |
| VCEL | VERICEL CORP | $5,024,000 | -61.6% | 2,232,940 | 0.0% | 0.71% | -64.1% | |
| AXGN | Buy | AXOGEN INC | $3,621,000 | +66.3% | 526,351 | +29.5% | 0.51% | +55.5% |
| SPNE | Buy | SEASPINE HLDGS CORP | $2,676,000 | +9.3% | 255,334 | +52.6% | 0.38% | +2.2% |
| BIOL | Buy | BIOLASE INC | $1,471,000 | -10.4% | 1,257,292 | +0.3% | 0.21% | -16.1% |
| VCYT | VERACYTE INC | $834,000 | -6.8% | 165,825 | 0.0% | 0.12% | -12.6% | |
| DSCI | Exit | DERMA SCIENCES INC | $0 | – | -181,818 | -100.0% | -0.00% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -95,000 | -100.0% | -3.85% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -833,000 | -100.0% | -7.20% | – |
| MACK | Exit | MERRIMACK PHARMACEUTICALS IN | $0 | – | -5,875,171 | -100.0% | -7.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 29 | Q2 2022 | 15.9% |
| ADMA BIOLOGICS INC | 27 | Q4 2020 | 2.3% |
| RETROPHIN INC | 23 | Q1 2020 | 11.3% |
| ANI PHARMACEUTICALS INC | 23 | Q3 2019 | 7.9% |
| VERICEL CORP | 21 | Q4 2019 | 5.5% |
| AMARIN CORP PLC | 14 | Q3 2019 | 14.4% |
| GLOBUS MED INC | 13 | Q2 2022 | 24.7% |
| ORTHOFIX INTL N V | 13 | Q3 2016 | 9.7% |
| PACIFIC BIOSCIENCES CALIF IN | 13 | Q4 2018 | 9.7% |
| CATALYST PHARM PARTNERS INC | 13 | Q3 2019 | 9.4% |
View Consonance Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | December 15, 2022 | 0 | 0.0% |
| ADMA BIOLOGICS, INC. | February 14, 2022 | 1,289,481 | 1.4% |
| ASSEMBLY BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| CASI Pharmaceuticals, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Cellectar Biosciences, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Gamida Cell Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| GenMark Diagnostics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Protagonist Therapeutics, IncSold out | February 14, 2022 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Consonance-HFW Acquisition Corp. | April 27, 2021 | 1,000,000 | 10.4% |
View Consonance Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-12-15 |
| SC 13D/A | 2022-12-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Consonance Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.